The answer to halting triple-negative breast cancer, the deadliest of all breast cancers, may have just been discovered by researchers from Boston Children’s Hospital.
A CRISPR gene-editing system — all encompassed into a nanogel capsule, that is then injected into the affected person’s body — is the potential antidote to stopping the growth of triple-negative breast cancer tumors.
RELATED: FIRST CRISPR USE INSIDE THE BODY WILL HELP TREAT BLINDNESS IN CHILDREN AND ADULTS
Comments are closed.